By using this site, you agree to the IDC Privacy Policy

Alan S. Louie, Ph.D.

Research Director, Life Sciences

Alan is responsible for directing the IDC Health Insights Life Sciences Practice. Dr. Louie manages a group of analysts who provide research-based advisory and consulting services for life sciences companies, technology vendors, and IT service providers across the life sciences value chain.  Within the practice, Dr. Louie leads IDC Health Insights' Life Science R&D Strategy and Technology Research service with coverage of ongoing innovation and best practices in life science R&D and a further emphasis on technology and innovation in clinical development, analytics, translational research, and precision medicine. 

BACKGROUND

Dr. Louie brings more than 32 years of technology, product and strategy development from across the life science industry.  Previously, Dr. Louie led applied biotechnology programs as Senior Manager at Arthur D. Little, Inc. In this role, he managed laboratory-based technology development programs, as well as provided content expertise to life science and healthcare strategy projects. Over his career, Dr. Louie was responsible for the development and commercialization of more than 30 products for a variety of industries, including many first-in-class product offerings.

EDUCATION/INDUSTRY ACCOMPLISHMENTS

·         Ph.D. in Biochemistry from the University of California at Riverside

·         B.A. in Biochemistry from the University of California at Berkeley

·         A recognized thought leader in both the health and life sciences industries

·         Frequent speaker, presenter, and moderator at industry conferences, including DIA, BioIT World, and Drug Discovery Technology World Congress

·         Highly regarded resource for the news media, with quotes in such renowned publications as the Boston Business Journal, The Boston Globe, Drug Discovery News, The Scientist, and The Wall Street Journal

·         More than 210 reports on innovation in the life sciences

 

Follow Dr. Louie on Twitter @IDCPharmaGuru.

 

This IDC Perspective provides analyst insights gathered from direct interviews with Amgen and TCS, combined with key industry trends associated with ongoing industry transformation. This document highlights Amgen's efforts to implement a di...
This IDC Perspective provides highlights and analysis of the recent Dassault Systèmes SIMULIA analyst event, held in Providence, Rhode Island."Dassault Systèmes has been building out its suite of simulation tools organically and through mul...
More results